Angiodynamics (ANGO) Share-based Compensation (2010 - 2026)

Angiodynamics (ANGO) has reported Share-based Compensation for 17 consecutive years, with $3.9 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Share-based Compensation rose 138.57% year-over-year to $3.9 million; the trailing twelve-month figure through May 2026 stood at $14.0 million (up 42.86% YoY), and the FY2026 full-year result was $14.0 million, up 42.86% from the prior year.
• Share-based Compensation climbed to $3.9 million in Q2 2026 per ANGO's latest filing, from $2.7 million in the prior quarter.
• Across five years, Share-based Compensation topped out at $4.5 million in Q3 2025 and bottomed at $1.6 million in Q2 2025.
• Historically, Share-based Compensation has averaged $2.8 million across 5 years, with a median of $2.8 million in 2025.
• The sharpest annual moves came in 2023 and 2026: Share-based Compensation plunged 43.97% in 2023, then jumped 138.57% in 2026.
• Over 5 years, Share-based Compensation stood at $3.4 million in 2022, then tumbled by 43.97% to $1.9 million in 2023, then jumped by 34.68% to $2.5 million in 2024, then climbed by 14.36% to $2.9 million in 2025, then jumped by 35.42% to $3.9 million in 2026.
• According to Business Quant data, Share-based Compensation over the past three periods registered $3.9 million, $2.7 million, and $2.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.